Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-22-008302
Filing Date
2022-02-17
Accepted
2022-02-17 18:54:11
Documents
1
Period of Report
2022-02-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 2731
  Complete submission text file 0001213900-22-008302.txt   4050
Mailing Address C/O CELSUS THERAPEUTICS PLC 24 WEST 40TH STREET NEW YORK NY 10018
Business Address
Shaw Allan (Reporting) CIK: 0001626850 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41294 | Film No.: 22650138

Mailing Address 2041 COURTLAND AVENUE CINCINNATI OH 45212
Business Address 2041 COURTLAND AVENUE CINCINNATI OH 45212 646-303-0737
Blue Water Vaccines Inc. (Issuer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations